<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-medicina-57-00217">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Pi</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <elocation-id>e0147157</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0147157</pub-id>
  <?supplied-pmid 26784960?>
  <pub-id pub-id-type="pmid">26784960</pub-id>
 </element-citation>
</ref>
